-
Mashup Score: 112Early Estimate of Nirsevimab Effectiveness for Prevention ... - 2 month(s) ago
This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants.
Source: www.cdc.govCategories: General Medicine News, General NewsTweet
-
Mashup Score: 143RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC - 2 month(s) ago
Beyfortus, a new shot for RSV, was 90% effective at preventing hospitalizations in children, new data shows.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Study Shows Low Number of Older Americans Are Vaccinated Against RSV - 2 month(s) ago
Only 9% of older adults who reside in the United States had been vaccinated to protect themselves from RSV this fall and winter.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest - 2 month(s) ago
The new vaccines that protect older adults against RSV may be linked to a small increased risk of developing Guillain-Barré syndrome, new data suggest.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 69stats - 2 month(s) ago
Learn about Respiratory Syncytial Virus (RSV) Immunizations Recs
Source: www.cdc.govCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7Increased Development of RSV Immunoprophylaxis Inhibited by Cost and Acquisition Barriers - 2 month(s) ago
Despite the growth in vaccine and antibody development for combatting RSV, lower income countries may not reap the benefits.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Live News Stream: Watch FOX 26 Houston - 2 month(s) ago
Stream local news and weather live from FOX 26 Houston. Plus watch LiveNow, FOX SOUL, and more exclusive coverage from around the country.
Source: www.fox26houston.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 7Increased Development of RSV Immunoprophylaxis Inhibited by Cost and Acquisition Barriers - 3 month(s) ago
Despite the growth in vaccine and antibody development for combatting RSV, lower income countries may not reap the benefits.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0How RSV Can Trigger Inflammation and Damage Nerve Cells - 3 month(s) ago
A new study has revealed that respiratory syncytial virus (RSV), the most common cause of lower respiratory tract infections, can infect nerve cells and trigger inflammation that may contribute to neurological symptoms. The study is the first to show that RSV can directly infect nerve cells.
Source: www.healthline.comCategories: General Medicine News, PediatricsTweet
-
Mashup Score: 0How RSV Can Trigger Inflammation and Damage Nerve Cells - 3 month(s) ago
A new study has revealed that respiratory syncytial virus (RSV), the most common cause of lower respiratory tract infections, can infect nerve cells and trigger inflammation that may contribute to neurological symptoms. The study is the first to show that RSV can directly infect nerve cells.
Source: www.healthline.comCategories: General Medicine News, PediatricsTweet
New @CDCMMWR: Early data show that nirsevimab — a preventive antibody for babies — was 90% effective in preventing babies from being hospitalized with RSV. To protect babies during #RSV season, nirsevimab is recommended October‒March. Learn more https://t.co/F0XmofjBPd https://t.co/e7XDMe1GaM